1st Counsel – Lifestyle
Author:
GEN Ilac ve Saglik Urunleri A.S.
GEN Receives Ethical Approval to Launch Phase II Clinical Trial for SUL-238 Targeting Mitochondrial Dysfunction in Patients with Parkinson’s Disease
March 16, 2026